SC
ORIAW

Sculptor Capital’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Sculptor Capital’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,981
Closed -$3.17K – 770
2022
Q4 		$3.17K Sell
17,981
-32,019
-64% -$3.68K ﹤0.01% 756
2022
Q3 		$9K Hold
50,000
– – ﹤0.01% 983
2022
Q2 		$9K Hold
50,000
– – ﹤0.01% 1107
2022
Q1 		$19K Hold
50,000
– – ﹤0.01% 1172
2021
Q4 		$49K Buy
50,000
+25,000
+100% +$26.1K ﹤0.01% 1078
2021
Q3 		$22K Buy
+25,000
New +$32.5K ﹤0.01% 950

Other funds holding ORIAW

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GAM
Gritstone Asset Management Bethesda, Maryland $104M AUM 6.03% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Sculptor Capital's ORIAW Position: Q1 2023 in Review

Sculptor Capital sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q1 2023, closing a stake of 17,981 shares — an estimated $3.17K sold.

Sculptor Capital first reported a position in ORIAW in Q3 2021 and held it in 6 quarters. The position peaked at $49K in Q4 2021. 25 funds tracked by Wall St. Rank hold ORIAW as of Q1 2023.

  • Sculptor Capital reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Sculptor Capital sold 17,981 Orion Biotech Opportunities Corp. Warrant shares in Q1 2023, an estimated $3.17K.
  • Sculptor Capital first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 6 quarters.
  • Sculptor Capital's Orion Biotech Opportunities Corp. Warrant position peaked at $49K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q1 2023.

Based on Sculptor Capital's 13F filing for Q1 2023, filed 16 May 2023.